Search results for: Innovation Policy Prize
Filter search results
The Many Faces of Innovation
1 June 2012
…economics of innovation, traces important innovation that has occurred since 2005, adds new… This report provides a clear explanation of the nature of innovation in medicines. A fully revised and…
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
…treatment options. Our report explores how supplier diversity can enhance healthcare resilience and drive innovation, with actionable recommendations for policymakers. Key takeaways Markets for rare disease (RD) medicines often lack…
Science Policy Research: Having an Impact on Policy?
1 December 2010
Professor Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) defines science policy research as ’economic, policy, management and organisational studies of science, technology and innovation (STI)…
Defining Innovation in Medicines and Transforming it into Value
3 July 2013
…of key European countries to valuing innovation in medicines and explained how actions by payers can affect the rate and direction of innovation. Defining Innovation in Medicines: How to Transform…
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
1 April 2011
…This monograph outlines a model that assesses the push, pull and hybrid approaches that could be applied to encourage innovation and suggest the size of the various incentives needed to…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key findings are summarised in…
Privacy Policy
This privacy policy is effective as of 15 November 2021. We review our privacy practices on an ongoing basis, and as such we may change this privacy policy from time…
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
1 March 2019
…Towse, A., Segel C.S., Henshall, C., Pearson, S.D. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates. Institute for Clinical and Economic Review and the…
Advancing Rare Disease Care: Challenges and Key Issues
28 February 2025
…of rare diseases; (2) improve incentives and access to innovation, and (3) create an enabling policy environment for advances in care. It all starts with patient data There are around…